Literature DB >> 24066737

Acute lung injury and fibrosis in a baboon model of Escherichia coli sepsis.

Ravi S Keshari1, Robert Silasi-Mansat, Hua Zhu, Narcis I Popescu, Glenn Peer, Hala Chaaban, John D Lambris, Holly Polf, Cristina Lupu, Gary Kinasewitz, Florea Lupu.   

Abstract

Sepsis-induced inflammation of the lung leads to acute respiratory distress syndrome (ARDS), which may trigger persistent fibrosis. The pathology of ARDS is complex and poorly understood, and the therapeutic approaches are limited. We used a baboon model of Escherichia coli sepsis that mimics the complexity of human disease to study the pathophysiology of ARDS. We performed extensive biochemical, histological, and functional analyses to characterize the disease progression and the long-term effects of sepsis on the lung structure and function. Similar to humans, sepsis-induced ARDS in baboons displays an early inflammatory exudative phase, with extensive necrosis. This is followed by a regenerative phase dominated by proliferation of type 2 epithelial cells, expression of epithelial-to-mesenchymal transition markers, myofibroblast migration and proliferation, and collagen synthesis. Baboons that survived sepsis showed persistent inflammation and collagen deposition 6-27 months after the acute episodes. Long-term survivors had almost double the amount of collagen in the lung as compared with age-matched control animals. Immunostaining for procollagens showed persistent active collagen synthesis within the fibroblastic foci and interalveolar septa. Fibroblasts expressed markers of transforming growth factor-β and platelet-derived growth factor signaling, suggesting their potential role as mediators of myofibroblast migration and proliferation, and collagen deposition. In parallel, up-regulation of the inhibitors of extracellular proteases supports a deregulated matrix remodeling that may contribute to fibrosis. The primate model of sepsis-induced ARDS mimics the disease progression in humans, including chronic inflammation and long-lasting fibrosis. This model helps our understanding of the pathophysiology of fibrosis and the testing of new therapies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24066737      PMCID: PMC3930952          DOI: 10.1165/rcmb.2013-0219OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  49 in total

Review 1.  Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants.

Authors:  F B Taylor
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

2.  Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids.

Authors:  G U Meduri; J M Belenchia; R J Estes; R G Wunderink; M el Torky; K V Leeper
Journal:  Chest       Date:  1991-10       Impact factor: 9.410

3.  Survivors of acute respiratory distress syndrome: relationship between pulmonary dysfunction and long-term health-related quality of life.

Authors:  Daren K Heyland; Dianne Groll; Manfred Caeser
Journal:  Crit Care Med       Date:  2005-07       Impact factor: 7.598

4.  Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis.

Authors:  Cristina Lupu; Andrew D Westmuckett; Glenn Peer; Lacramioara Ivanciu; Hua Zhu; Fletcher B Taylor; Florea Lupu
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

5.  Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis.

Authors:  Robert Silasi-Mansat; Hua Zhu; Narcis I Popescu; Glenn Peer; Georgia Sfyroera; Paola Magotti; Lacramioara Ivanciu; Cristina Lupu; Tom E Mollnes; Fletcher B Taylor; Gary Kinasewitz; John D Lambris; Florea Lupu
Journal:  Blood       Date:  2010-05-13       Impact factor: 22.113

Review 6.  The role of osteopontin in lung disease.

Authors:  Anthony O'Regan
Journal:  Cytokine Growth Factor Rev       Date:  2003-12       Impact factor: 7.638

7.  Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients.

Authors:  C Martin; L Papazian; M J Payan; P Saux; F Gouin
Journal:  Chest       Date:  1995-01       Impact factor: 9.410

8.  Sepsis-induced acute respiratory distress syndrome with fatal outcome is associated to increased serum transforming growth factor beta-1 levels.

Authors:  Raúl de Pablo; Jorge Monserrat; Eduardo Reyes; David Díaz; Manuel Rodríguez-Zapata; Antonio de la Hera; Alfredo Prieto; Melchor Alvarez-Mon
Journal:  Eur J Intern Med       Date:  2011-11-06       Impact factor: 4.487

9.  EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer.

Authors:  Alexandria M Haslehurst; Madhuri Koti; Moyez Dharsee; Paulo Nuin; Ken Evans; Joseph Geraci; Timothy Childs; Jian Chen; Jieran Li; Johanne Weberpals; Scott Davey; Jeremy Squire; Paul C Park; Harriet Feilotter
Journal:  BMC Cancer       Date:  2012-03-19       Impact factor: 4.430

10.  One year outcomes in patients with acute lung injury randomised to initial trophic or full enteral feeding: prospective follow-up of EDEN randomised trial.

Authors:  Dale M Needham; Victor D Dinglas; O Joseph Bienvenu; Elizabeth Colantuoni; Amy W Wozniak; Todd W Rice; Ramona O Hopkins
Journal:  BMJ       Date:  2013-03-19
View more
  13 in total

Review 1.  Crosstalk between the coagulation and complement systems in sepsis.

Authors:  Florea Lupu; Ravi S Keshari; John D Lambris; K Mark Coggeshall
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

2.  Inter-α inhibitor protein and its associated glycosaminoglycans protect against histone-induced injury.

Authors:  Hala Chaaban; Ravi S Keshari; Robert Silasi-Mansat; Narcis I Popescu; Padmaja Mehta-D'Souza; Yow-Pin Lim; Florea Lupu
Journal:  Blood       Date:  2015-01-28       Impact factor: 22.113

Review 3.  The Basic Science and Molecular Mechanisms of Lung Injury and Acute Respiratory Distress Syndrome.

Authors:  Paola Aranda-Valderrama; Ata Murat Kaynar
Journal:  Int Anesthesiol Clin       Date:  2018

4.  DNA and factor VII-activating protease protect against the cytotoxicity of histones.

Authors:  Gerben Marsman; Helen von Richthofen; Ingrid Bulder; Florea Lupu; Jan Hazelzet; Brenda M Luken; Sacha Zeerleder
Journal:  Blood Adv       Date:  2017-11-30

5.  Loss of myeloid-specific protein phosphatase 2A enhances lung injury and fibrosis and results in IL-10-dependent sensitization of epithelial cell apoptosis.

Authors:  Lei Sun; Elissa M Hult; Timothy T Cornell; Kevin K Kim; Thomas P Shanley; Carol A Wilke; Manisha Agarwal; Stephen J Gurczynski; Bethany B Moore; Mary K Dahmer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-06       Impact factor: 5.464

Review 6.  Complement in paroxysmal nocturnal hemoglobinuria: exploiting our current knowledge to improve the treatment landscape.

Authors:  Dimitrios C Mastellos; Daniel Ricklin; Despina Yancopoulou; Antonio Risitano; John D Lambris
Journal:  Expert Rev Hematol       Date:  2014-09-02       Impact factor: 2.929

Review 7.  Mechanisms of Lung Fibrosis Resolution.

Authors:  Stephan W Glasser; James S Hagood; Simon Wong; Carmen A Taype; Satish K Madala; William D Hardie
Journal:  Am J Pathol       Date:  2016-03-25       Impact factor: 4.307

Review 8.  Escherichia coli and Sudden Infant Death Syndrome.

Authors:  Karl A Bettelheim; Paul N Goldwater
Journal:  Front Immunol       Date:  2015-07-03       Impact factor: 7.561

9.  Tryptase is involved in the development of early ventilator-induced pulmonary fibrosis in sepsis-induced lung injury.

Authors:  Jesús Villar; Nuria E Cabrera-Benítez; Francisco Valladares; Sonia García-Hernández; Ángela Ramos-Nuez; José Luís Martín-Barrasa; Mercedes Muros; Robert M Kacmarek; Arthur S Slutsky
Journal:  Crit Care       Date:  2015-04-03       Impact factor: 9.097

10.  Complement inhibition decreases early fibrogenic events in the lung of septic baboons.

Authors:  Robert Silasi-Mansat; Hua Zhu; Constantin Georgescu; Narcis Popescu; Ravi S Keshari; Glenn Peer; Cristina Lupu; Fletcher B Taylor; Heloise Anne Pereira; Gary Kinasewitz; John D Lambris; Florea Lupu
Journal:  J Cell Mol Med       Date:  2015-09-03       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.